Insmed (INSM) Non Operating Income (2013 - 2014)
Insmed (INSM) posted quarterly Non Operating Income of -$19000.0 for Q1 2014, down 1050.0% year-over-year from $2000.0 in Q1 2013, and down 1050.0% quarter-over-quarter from $2000.0 in Q1 2013.
Powered by 
Analysis
Insmed (INSM) Non Operating Income (2013 - 2014) Analysis & Trends
Insmed's Non Operating Income history runs 2 years deep, the most recent figure standing at -$19000.0 for Q1 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -139.24 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -51.63 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.61 Bn | 21.07 Bn | 1.57 Bn | - |